Method for quantitative characterization of substances with regard to their properties of binding to amyloid-β (Aβ) conformers

Patent metadata

Field	Value
Publication number	US-10746747-B2
Application number	US-201414902760-A
Country	US
Kind code	B2
Filing date	Jun 25, 2014
Priority date	Jul 12, 2013
Publication date	Aug 18, 2020
Grant date	Aug 18, 2020

Abstract

A method for the quantitative characterization of substances with regard to their properties of binding to amyloid-β (Aβ) conformers, comprising the steps of: —fractionating a sample including various Aβ conformers; —immobilizing a biotinylated Aβ conformer of the desired fraction on the surface of a substrate having high affinity for biotin; and —deriving the binding behavior of an aggregate quality control probe to the desired Aβ conformer from the measurement signal by determining the kinetic and/or thermodynamic parameters. A device for carrying out the method.

First claim

The invention claimed is:

1. A method for the quantitative characterization of substances with regard to their properties of binding to amyloid-β (Aβ) conformers, comprising the steps of:
a) preparing in a sample comprising Aβ and N-terminally biotinylated Aβ, and incubating the sample so that various conformers of Aβ are present in the sample though aggregation;
b) fractionating the sample comprising various Aβ conformers by gradient centrifugation to fractionate and separate the various Aβ conformers;
c) immobilizing a biotinylated Aβ conformer of a desired fraction, which Aβ conformer is non-monomeric, on the surface of a substrate having high affinity for biotin;
d) adding an aggregate control probe to the immobilized biotinylated Aβ conformer;
e) determining kinetic and/or thermodynamic parameters of any binding to the Aβ conformer, and obtaining measurement signal; and
f) deriving the binding behavior of the aggregate quality control probe to the desired Aβ conformer from the measurement signal, so as to thereby check the quality of the immobilized aggregates;
wherein a ratio of N-terminally biotinylated to non-biotinylated molecules in a mixture used to produce the sample in step a) is less than or equal to 1:10 to 1:40 or wherein a ratio of N-terminally biotinylated to non-biotinylated molecules in a mixture used to produce the sample in step a) is 1:100.

2. The method according to claim 1 , further comprising a step of preparing a sample comprising Aβ and N-terminally biotinylated Aβ or comprising exclusively N-terminally biotinylated Aβ, and incubating said sample so that various conformers of Aβ are present in the sample through aggregation.

3. The method according to claim 1 , wherein the sample including Aβ conformers in step a) was obtained from cell culture or by removal from a body.

4. The method according to claim 1 , wherein a ratio of N-terminally biotinylated to non-biotinylated molecules in a mixture used to produce the sample in step a) is 1:10 or 1:40 or 1:100.

5. The method according to claim 1 , wherein the aggregate quality control probe is antibody fragment scFv-IC16.

6. The method according to claim 1 , comprising carrying out surface plasmon resonance or biolayer interferometry to determine the kinetic and/or thermodynamic parameters.

7. The method according to claim 1 , wherein a ratio of N-terminally biotinylated to non-biotinylated molecules in a mixture used to produce the sample in step a) is less than or equal to 1:10 to 1:40.

8. The method according to claim 1 , wherein the aggregate quality control probe dissociates from Aβ.

9. The method according to claim 8 , wherein a substance to be tested is added to the immobilized conformer and the binding behavior of the substance to be tested to the desired Aβ conformer is derived from the measurement signal by determining the kinetic and/or thermodynamic parameters.

10. The method according to claim 9 , wherein the substance to be tested is a peptide D7 having the sequence of SEQ ID No. 1.

11. The method according to claim 9 , wherein the substance to be tested dissociates from the Aβ conformer.

12. The method according to claim 11 , wherein after the substance to be tested dissociates from the Aβ conformer, the aggregate quality control probe is again added to the conformer and the surface of the substrate is checked with regard to the quality for further binding studies.

Assignees

• Forschungszentrum Juelich Gmbh

Inventors

• Willbold Dieter
• Glueck Julian
• Frenzel Daniel
• Nagel-Steger Luitgard
• Brener Oleksandr

Classifications

• G01N33/54366 Primary

  Apparatus specially adapted for solid-phase testing · CPC title

• G01N2333/4709

  Amyloid plaque core protein · CPC title

• G01N33/6896 Primary

  Neurological disorders, e.g. Alzheimer's disease · CPC title

• G01N33/54373

  involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings · CPC title

• G01N2500/20

  cell-free systems · CPC title